Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[DNA arrays: technological aspects and applications].

F Bertucci1, B Loriod, R Tagett

  • 1Centre d'immunologie de Marseille-Luminy, BP 9, 13288 Marseille Cedex 9, France.

Bulletin Du Cancer
|April 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inclusive Search for Anomalous Single-Photon Production in MicroBooNE.

Physical review letters·2026
Same author

First Search for Dark Sector e^{+}e^{-} Explanations of the MiniBooNE Anomaly at MicroBooNE.

Physical review letters·2026
Same author

First Measurement of Charged-Current Muon-Neutrino-Induced K^{+} Production on Argon Using the MicroBooNE Detector.

Physical review letters·2026
Same author

GLOW: Gastric LOW-Rank Tensor-Based Motion Correction for Abdominal 4D MRI.

NMR in biomedicine·2025
Same author

Search for an Anomalous Production of Charged-Current ν_{e} Interactions without Visible Pions across Multiple Kinematic Observables in MicroBooNE.

Physical review letters·2025
Same author

First Measurement of ν_{e} and ν[over ¯]_{e} Charged-Current Single Charged-Pion Production Differential Cross Sections on Argon Using the MicroBooNE Detector.

Physical review letters·2025
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

DNA microarrays enable large-scale gene analysis for functional genomics, revolutionizing biomedical research. This technology advances understanding of diseases like cancer, leading to new therapies and diagnostics.

Area of Science:

  • Genomics and functional genomics
  • Biomedical research technologies

Context:

  • The Human Genome Project and other sequencing initiatives have accelerated biological data accumulation.
  • Advancements in genomic sequencing enable large-scale molecular analyses and protein functional annotation.
  • DNA microarray technology has emerged as a dominant tool in functional genomics due to its accessibility and versatility.

Purpose:

  • To present the approaches and potential applications of DNA microarray technology.
  • To highlight the role of DNA microarrays in functional genomics and biomedical research.
  • To explore the specific applications of DNA microarrays in cancer research.

Summary:

  • DNA microarrays allow simultaneous analysis of thousands of genes at the genome or transcriptome level in biological samples.

Related Experiment Videos

  • They facilitate a deeper understanding of molecular interaction networks in healthy and diseased states.
  • This technology enables precise genetic characterization of pathological mechanisms.

    • Impact:

    • Expected to drive major advances in health sciences and personalized medicine.
    • Facilitates identification of novel therapeutic targets and development of new pharmaceuticals.
    • Enables definition of new pathological subclasses and identification of biomarkers for disease susceptibility and treatment response.